[Federal Register Volume 61, Number 31 (Wednesday, February 14, 1996)]
[Notices]
[Page 5787]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-3324]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Docket No. 96G-0035]
Solvay Enzymes, Inc.; Filing of Petition for Affirmation of GRAS
Status
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that
Solvay Enzymes, Inc., has filed a petition (GRASP 6G0420) proposing to
affirm that the use of dextranase enzyme preparation derived from
Chaetomium gracile is generally recognized as safe (GRAS) in cane and
beet sugar processing.
DATES: Written comments by April 29, 1996.
ADDRESSES: Submit written comments to the Dockets Management Branch
(HFA-305), Food and Drug Administration, 12420 Parklawn Dr., rm. 1-23,
Rockville, MD 20857.
FOR FURTHER INFORMATION CONTACT: Martha D. Peiperl, Center for Food
Safety and Applied Nutrition (HFS-217), Food and Drug Administration, -
200 C St. SW., Washington, DC 20204, 202-418-3077.
SUPPLEMENTARY INFORMATION: Under the Federal Food, Drug, and Cosmetic
Act (secs. 201(s) and 409(b)(5) (21 U.S.C. 321(s) and 348(b)(5)) and
the regulations for affirmation of GRAS status in Sec. 170.35 (21 CFR
170.35), notice is given that Solvay Enzymes, Inc.,
c/o 1001 G St. NW, suite 500 West, Washington, DC 20001, has filed a
petition (GRASP 6G0420) proposing that dextranase enzyme preparation
derived from Chaetomium gracile be affirmed as GRAS for use in cane and
beet sugar processing.
The petition has been placed on display at the Dockets Management
Branch (address above).
Any petition that meets the requirements outlined in Secs. 170.30
(21 CFR 170.30) and 170.35 is filed by the agency. There is no
prefiling review of the adequacy of data to support a GRAS conclusion.
Thus, the filing of a petition for GRAS affirmation should not be
interpreted as a preliminary indication of suitability for GRAS
affirmation.
The potential environmental impact of this action is being
reviewed. If the agency finds that an environmental impact statement is
not required and this petition results in a regulation, the notice of
availability of the agency's finding of no significant impact and the
evidence supporting that finding will be published with the regulation
in the Federal Register in accordance with 21 CFR 25.40(c).
Interested persons may, on or before April 29, 1996, review the
petition and file comments with the Dockets Management Branch (address
above). Two copies of any comments should be filed and should be
identified with the docket number found in brackets in the heading of
this document. Comments should include any available information that
would be helpful in determining whether the substance is, or is not,
GRAS for the proposed use. In addition, consistent with the regulations
promulgated under the National Environmental Policy Act (40 CFR
1501.4(b)), the agency encourages public participation by review of and
comment on the environmental assessment submitted with the petition
that is the subject of this notice. A copy of the petition (including
the environmental assessment) and received comments may be seen in the
Dockets Management Branch between 9 a.m. and 4 p.m., Monday through
Friday.
Dated: January 29, 1996.
Alan M. Rulis,
Director, Office of Premarket Approval, Center for Food Safety and
Applied Nutrition.
[FR Doc. 96-3324 Filed 2-13-96; 8:45 am]
BILLING CODE 4160-01-F
